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Edited by C. KalodimosAbstractThe 155-kDa plasma glycoprotein factor H (FH), which consists of 20 complement control protein (CCP)
modules, protects self-tissue but not foreign organisms from damage by the complement cascade. Protection
is achieved by selective engagement of FH, via CCPs 1–4, CCPs 6–8 and CCPs 19–20, with polyanion-rich
host surfaces that bear covalently attached, activation-specific, fragments of complement component C3.
The role of intervening CCPs 9–18 in this process is obscured by lack of structural knowledge. We have
concatenated new high-resolution solution structures of overlapping recombinant CCP pairs, 10–11 and 11–
12, to form a three-dimensional structure of CCPs 10–12 and validated it by small-angle X-ray scattering of
the recombinant triple‐module fragment. Superimposing CCP 12 of this 10–12 structure with CCP 12 from the
previously solved CCP 12–13 structure yielded an S-shaped structure for CCPs 10–13 in which modules are
tilted by 80–110° with respect to immediate neighbors, but the bend between CCPs 10 and 11 is counter to
the arc traced by CCPs 11–13. Including this four-CCP structure in interpretation of scattering data for the
longer recombinant segments, CCPs 10–15 and 8–15, implied flexible attachment of CCPs 8 and 9 to CCP
10 but compact and intimate arrangements of CCP 14 with CCPs 12, 13 and 15. Taken together with
difficulties in recombinant production of module pairs 13–14 and 14–15, the aberrant structure of CCP 13 and
the variability of 13–14 linker sequences among orthologues, a structural dependency of CCP 14 on its
neighbors is suggested; this has implications for the FH mechanism.
© 2012 Elsevier Ltd. Open access under CC BY license.Introduction
The activated complement system1–3 assists in
clearance of pathogens in addition to debris from
diseased, damaged, dead or dying cells. Hydrolysis
of a thioester linkage in complement component C3,
yielding C3(H2O), is the rare, spontaneous but
ubiquitous initiating event of the “alternative” path-
way of the complement cascade.4 C3(H2O) collab-
orates with proenzyme factor B and proteolytic factor0022-2836/© 2012 Elsevier Ltd. Open access under CC BY license.D to create the convertase complex C3(H2O).Bb that
converts C3 to C3a (an anaphylatoxin) and C3b.
C3b is able to rapidly attach covalently to any nearby
surface and to form C3b.Bb [a structural and
functional analogue of C3(H2O).Bb] that, in a
positive-feedback loop,5 converts additional C3 to
C3b. Particles become coated (“opsonised”) with
C3b and are then subject to immune clearance.
Moreover, C3b participates in both “classical” and
“lectin” pathways; all three pathways feed into theJ. Mol. Biol. (2012) 424, 295–312
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C5a and culminates in the assembly of potentially
cytolytic pores.
Distinction by the alternative pathway between self
and nonself is not driven by discriminatory covalent
attachment of C3b.4,6 Rather, it is accomplished
mainly by selective action of factor H (FH), comple-
ment receptor type 1 (CR1), membrane cofactor
protein (MCP) and decay accelerating factor (DAF).7
Either through being host-membrane bound (CR1,
DAF or MCP) or (in the case of FH) via selective
association with host-cell‐specific markers,8 these
regulators prevent amplification of C3b on self-
surfaces. They (DAF, CR1 and FH) perturb forma-
tion and stability of C3b.Bb or (CR1, FH and MCP)
recruit factor I to cleave C3b, removing it from the
amplification loop that continues to operate on, for
example, a bacterium. The product, iC3b, cannot
form a complex with Bb but remains an opsonin and
a ligand for receptors on immune cells.9
The abundant10 plasma regulator FH (155kDa,
1213 residues)11,12 fails to adequately protect host
tissues from complement-mediated damage over
the lifetimes of many individuals who possess CFH
polymorphisms or mutations.13 Age-related macular
degeneration is a prominent example of a disease
arising from such a deficiency.14 To explain the
molecular bases for these disorders, it is essential to
understand why wild-type FH is significantly more
active on healthy self-cells than on diseased or
foreign ones.15 Moreover, as a self-tissue‐specific
regulator of C3 activation, knowledge of the struc-
ture–function relationships of FH16 could inspire
design of therapeutic complement inhibitors useful in
the wide range of conditions where complement
plays a damaging role.13,17–19
FH consists entirely of 20 complement control
protein (CCP) modules20 of between 51 and 62
residues each, connected by linking sequences of
between 3 and 8 residues in length21,22 (Fig. 1).
Successful crystallization of FHhas not been reported.
Current structural knowledge draws on data from
small-angle X-ray scattering (SAXS), analytical ultra-
centrifugation and electron microscopy23–26 com-
bined with high-resolution structures for short
discontinuous segments of the protein.27–36
The N-terminal CCPs 1–4 and the C-terminal
CCPs 19–20 of FH bind C3b at adjacent, nonover-
lapping sites.34,37,38 Like full-length FH, a recombi-
nant fragment consisting solely of CCPs 1–4 (i.e., FH
1–4) not only competes with binding of factor B to
C3b in solution but also recruits factor I.39–42 In
addition, FH has sites within CCPs 6–8 and CCPs
19–20 that interact with polyanionic self-surface
markers and are critical for specificity.37,43–46 Nearly
all disease-linked sequence variations occur at
these C3b-binding or polyanion-binding regions of
FH13 in which CCPs adopt extended end-to-end
arrangements connected by linkers of three or fourresidues. The central modules of FH (CCPs 9–18),
on the other hand, do not contain strong binding sites
for polyanions or C3b.37 Thus, tethering together the
two C3b/polyanion-binding sites, CCPs 1–8 and
CCPs 19–20, might produce an eff ic ient
biopharmaceutical.47 However, knowledge on the
role of the intervening 10 modules of FH that are
hypothesized to enhance the specificity of FH for
self-surface protection is lacking.
This central region has long inter‐modular linkers (6,
6, 8, 7 and 5 residues for CCPs 10–11, 11–12, 12–13,
13–14 and 14–15, respectively) (Fig. 1), relatively
small modules (51 residues in CCP 13), and
accommodates seven of eight utilized N-glycosylation
sites in FH.48 Initial notions that CCPs 9–18 merely
form a flexible tether between C3b-binding and
polyanion-recognition regions were disproved by
studies of FH 10–15.35 This molecule failed to
crystallize, but a SAXS-derived structural model
guided by an NMR-derived FH 12–13 structure was
created. The FH 10–15 construct forms a compact
rather than flexible or elongated structure.
Here, we describe recombinant production of the
remaining bi-modules (i.e., besides FH 12–13) from
the FH 10–15 region and their structural investiga-
tion. While samples of FH 13–14 and FH 14–15,
unusually for CCP bi-modules, resisted all attempts
at preparation in our hands, structures of FH 10–11
and FH 11–12 were readily determined by NMR. A
structure of FH 10–12, produced by combining these
two high-resolution solution structures, was validat-
ed by SAXS. A subsequently constructed model of
FH 10–13 allowed reinterpretation of SAXS data for
FH 10–15 and FH 8–15. It seems that CCPs 13–15
are compacted, while CCP 14 appears unstable
unless it is folded back along CCPs 12 and 13.
These possibilities are discussed in terms of the
mechanism of FH.Results
FH 10–11 and FH 11–12, but not FH 13–14 or FH
14–15, yielded assignable NMR spectra
We set out to investigate whether the large tilt angle
(~80°) previously observed between CCPs 12 and
1335 is a consistent feature across the central seg-
ment of FH. Like FH 12–13, samples of FH 10–11
and FH 11–12 were straightforward to prepare.
Moreover, they gave [1H,15N]heteronuclear single
quantum coherence (HSQC) spectra of high quality
with the expected numbers of well‐dispersed cross-
peaks (Fig. 2a and b) for stably folded proteins.
Other overlapping bi-modules within the FH 10–15
region—FH 13–14 and FH 14–15—proved intracta-
ble. Recombinant FH 13–14 was prone to proteol-
ysis and self-association; nevertheless, a 15N-
Fig. 1. Gaps in structural knowledge of human complement FH. Drawn as ovals, CCPs are shaded to indicate C3b-
binding regions or emboldened to signify GAG/sialic acid-recognition sites (CCPs 7 and 20 being the most strongly
implicated). The number of residues in each inter-modular linker is written beneath; above is a schematic representation of
the tilt angle (away from linearity) of a CCP's long axis with respect to the long axis of the preceding CCP [including (bold)
FH 10–11 and FH 11–12 tilts measured herein]. The tilt between CCPs 18 and 19 was 122° in the FH 18–20 crystal
structure,36 but SAXS suggested a more extended arrangement in solution. Structures solved by NMR or X-ray
crystallography of recombinant segments of FH are summarized in the central portion of the figure. “Current work”
summarizes the recombinant constructs investigated and methods used for analysis.
297Structures of Factor H Modules 10–11 and 11–12labeled sample eluting as a monomeric species was
obtained from a calibrated size-exclusion chroma-
tography column and produced a single band, of the
expected size, by sodium dodecyl sulfate–polyacryl-
amide gel electrophoresis. Unexpectedly, this FH
13–14 sample must have been improperly folded
since, under a range of conditions, it yielded
[1H,15N]HSQC spectra (Supplementary Fig. S1)
dominated by overlapped, broad cross-peaks. An
overlay of this spectrum with a [1H,15N]HSQC
spectrum of FH 13 (previously expressed as an
isolated module35) showed that only a few weak
cross-peaks from compactly folded CCP 13 could
be detected in the CCP 13–14 spectrum (Supple-
mentary Fig. S1). In the case of FH 14–15, no
sample suitable for NMR data collection could be
prepared due to excessive propensity for proteolysis
and oligomerization.Modules 10–12 do not form a highly
elongated structure
SAXS curves were collected for FH 10–11, FH
11–12 andFH10–12; neither FH 13–14 nor FH14–15
samples were suitable. Analysis of parameters
extracted from scattering profiles and real-space
distance distribution functions, p(r), reveals mono-mers (Fig. 3 and Table 1) consistent with their elution
volumes from size-exclusion chromatography col-
umns. Bi-modules FH 10–11 and FH 11–12 yielded
similar radii of gyration (Rg) and maximum particle
dimensions (Dmax), but FH 11–12 (Rg=2.4nm and
Dmax=8.3nm) was slightly more extended than
FH 10–11 (Rg=2.2nm and Dmax=7.5nm). The posi-
tively skewed p(r) functions of both bi-modules are
characteristic of dumbbell-shaped structures; the first
maximum represents a common average intra-
module distance (~1.7nm), and the second maxi-
mum represents an approximate average separation
of the centers of mass of the two CCPs (~ 3.8nm).
Studies of tri-modular FH 10–12 yielded only a
modest 0.1‐ to 0.3‐nm increase in Rg and 0.8‐ to
1.2‐nm increase inDmax (Fig. 3 and Table 1). The p(r)
function of FH 10–12 shows a shift in the position of
the first maximum relative to that of bi-modules; this
reflects an increase in effective cross-section upon
addition of the third CCP. These observations clearly
demonstrate that FH 10–12 does not have an
elongated structure similar to FH 1–333 or FH 6–8.32
Three-dimensional structures of FH 10–11 and
FH 11–12
TheNMRspectra (13C,15N) for FH10–11 and 11–12
(Fig. 2a and b) enabled near-complete assignment
Fig. 2 (legend on next page)
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Fig. 3. SAXS data for FH constructs: pairwise intera-
tomic distance distributions, p(r), for the following con-
structs derived from FH, FH 8–9, FH 10–11, FH 11–12, FH
10–12 and FH 8–15.
299Structures of Factor H Modules 10–11 and 11–12of 1H, 15N and 13C (Table 2). Following manual
partial assignment of 15N‐ and 13C-filtered nuclear
Overhauser enhancement (NOE) spectroscopy
spectra, we input a provisional list of NOE assign-
ments into the first of seven CYANA cycles of
structure calculations.49 CYANA-derived distance
restraints were used for calculations of structures in
CNS (Crystallography and NMR System).50 The 20
lowest-energy CNS-derived structures converged
well and were refined in explicit aqueous solvent
(Fig. 4a and b; Table 2). Note (as discussed further
below) that near-identical structures resulted from a
calculation that incorporated both NOEs and SAXS-
derived parameters.
The β-strand-rich structures of CCPs 10, 11 and
12 (Fig. 4c and d) contain Cys(I)–Cys(III) and
Cys(II)–Cys(IV) disulfides. The consensus Trp is
buried in the cores of CCPs 11 and 12; a Leu
occupies this position in CCP 10. STRIDE-
identified51 β-strands were labeled (in Fig. 4c and
d) according to a convention recognizing the
occurrence of maximally eight β-strands (A–H), at
conserved positions, within CCP structures.29,52
Slowly exchanging amide protons (Supplementary
Fig. S2) coincided with either burial or engagement
in hydrogen bonds; after 15min of D2O exposure,
the following numbers of HSQC cross-peaks
remained: 2 in CCP 10 and 22 in CCP 11 (none in
the linker) for FH 10–11, and 17 in CCP 11 and 9 in
CCP 12 (1 in the linker) for FH 11–12. Although CCP
10 has more extensive β-strands, CCPs 11 and 12
have more slowly exchanging amides.
Structures of CCP 10 or 11 converged well when
the ensemble of NOE-derived FH 10–11 structures
was overlaid solely on either module; CCP 11 or 12Fig. 2. NMR data ([1H,15N]HSQC spectra) for FH 10–11 a
collected in 30min on double-labeled samples (0.45mM and 0
20mM potassium phosphate buffer (at pH6.7 and 6.3 for FH 1within the FH 11–12 ensemble likewise converged
well on a per-module basis (Fig. 4a and b). The
structure of CCP 11 from FH 10–11 overlaid well
with the structure of CCP 11 from the FH 11–12
structure; moreover, CCP 12 solved in the current
work overlaid well on CCP 12 from FH 12–13
(Supplementary Fig. S3 and Table S1). That module
structures were conserved in FH 10–11, FH 11–12
and FH 12–13 endorsed construction of models of
longer FH segments by concatenating bi-module
structures (see below). While CCP 10's structure
does not resemble the structures of other FH CCPs
(backbone rmsdN2Å; Table S1), it is similar to MCP
CCP 353 (Supplementary Fig. S4a). CCP 12 is very
similar in structure to CCP 2 of complement receptor
type 254 (Supplementary Fig. S4b). FH CCPs 11
and 12 resemble one another and are similar to FH
CCPs 18 and 1936 (Supplementary Fig. S4c and
Table S1).NOE-derived structures are not under-restrained
or over-restrained
Within each bi-module, ~120 NOEs were identified
between modules and their linker (Table 2). Eight
NOEs were found directly between CCPs 10 and 11,
compared to 38 NOEs between CCPs 11 and 12;
thus, a network of NOEs that was more extensive for
FH 11–12 than FH 10–11 defines the inferred inter-
modular orientations. Indeed, the FH 10–11 struc-
tures exhibited good convergence when overlaid
over both modules, and a comparable result was
obtained for FH 11–12. Moreover, relaxation data
(Supplementary Fig. S5) showed that inter‐modular
linkers are not more mobile than other extended
regions of the polypeptide. Nonetheless, several
further steps were taken to check that these
FH 10–11 and FH 11–12 solution structures were
neither over-restrained nor under-restrained.
First, bi-module structures were recalculated using
an ensemble-based simulated annealing protocol (in
Xplor-NIH).55,56 This allows simultaneous genera-
tion of an ensemble of n conformers that, between
them, satisfy all NOE-derived distance restraints.
With the use of an ensemble size (n) of 2, ensemble
members turned out to be nearly identical with one
another and to the outcome of a standard simulated
annealing protocol (i.e., effectively, n=1); thus, we
found no evidence that FH 10–11 or FH 11–12
adopts multiple conformers interconverting on the
NOE timescale.
Second, NOE (only)-derived structures of FH 10–11
were fit to the FH 10–11 SAXS data (using
CRYSOL57) with discrepancies (χ) (between datand FH 11–12. Spectra [(a) FH 10–11; (b) FH 11–12] were
.65mM FH 10–11 and FH 11–12, respectively) at 25°C in
0–11 and FH 11–12, respectively).
Table 1. SAXS parameters for FH fragments
Construct Rg
autoRg (nm) Rg
GNOM (nm) Dmax (nm) Vp (nm
3) MMSAXS (kDa) VDAM (nm
3) MMDAM (kDa)
FH 8–9 (13.7kDa) 2.1±0.1 2.2±0.1 7.5±0.5 21±5 15±5 23±5 11±5
FH 10–11 (13.9kDa) 2.2±0.1 2.2±0.1 7.5±0.5 22±5 16±5 21±5 10±5
FH 11–12 (14.1kDa) 2.4±0.1 2.3±0.1 8.3±0.5 25±5 19±5 25±5 12±5
FH 10–12 (20.6kDa) 2.7±0.1 2.7±0.1 9.5±0.5 33±5 20±5 47±5 24±5
FH 8–15 (54.7kDa) 3.5±0.1 3.7±0.1 12.5±0.5 92±10 62±5 93±10 47±5
Rg
autoRg and Rg
GNOM are the radii of gyration estimated from the SAXS data using the automated Guinier analysis routine and GNOM,
respectively. Dmax, Vp, VDAM, MMSAXS and MMDAM are the maximum particle dimension, hydrated particle volume, dummy-atom model
total excluded volume, molecular mass estimated from I(0) and molecular mass estimated from the dummy-atom model volume,
respectively. The data shown are averaged or merged and extrapolated to infinite dilution, using the SAXS profiles recorded at several
concentrations. The molecular mass calculated from the sequence is shown in parentheses.
300 Structures of Factor H Modules 10–11 and 11–12and model) of 1.3–1.6; equivalent values for FH 11–
12 were 1.6–2.2 (Supplementary Fig. S6a). Thus, for
both bi-modules, the NMR-derived structures pro-
vide a good fit to the scattering data. Furthermore, in
an ab initio approach, the average structures of both
bi-modules were reconstructed from SAXS data
(using DAMMIF58). Within each set of 10 indepen-
dent reconstructions, highly similar shapes were
obtained, with low (b1.0) normalized spatial
discrepancies.59 Importantly, discrepancies be-
tween these models and high-resolution NMR-
derived structures were small (χ=0.9–1.2) in both
cases. When averaged and volume-fitted ab initioTable 2. Statistics for solution structures of FH 10–11 and
FH 11–12
Segment FH 10–11 FH 11–12
Numbers of NOE-derived distance restraints
Intraresidue, |i− j|≤1 1405 1482
Medium range, 1b |i− j|b5 411 301
Long range, |i− j|≥5 1391 1322
Total 3207 3105
Inter‐modulara 8 38
N-module to linker 62 89
C-module to linker 65 39
rmsd values (Å) (superimposition of ensemble over entire sequence)
All atoms 1.17 1.05
Backbone atoms 0.91 0.84
rmsd values (Å) (superimposition of ensemble over N-terminal CCP)
All atoms 0.79 0.73
Backbone atoms 0.50 0.33
rmsd values (Å) (superimposition of ensemble over C-terminal CCP)
All atoms 0.74 0.72
Backbone atoms 0.33 0.43
Inter‐modular angles (°) [minimum–maximum (mean±SD)]
Skew 75–107 (89±8) 149–170 (158±4)
Twist 40–78 (57±10) 59–87 (72±7)
Tilt 111–128 (118±5) 76–99 (88±6)
Ramachandran assessment (%)
Most favored 80.5 74.6
Additionally allowed 16.4 22.4





a Module boundaries defined by the first and the last cysteine of
each CCP module.
b This value is for the closest-to-mean structures in each
ensembles (see Materials and Methods).shapes were superimposed with the corresponding
NMR ensembles using SUPCOMB,59 good spatial
agreement was observed (Supplementary Fig. S6b),
thus validating the NMR-derived structures.
Finally, structure calculations (with ensemble
sizes of 1 and 2) were conducted for each bi-module
with incorporation of both NOE and SAXS data60 as
experimental structural restraints.61 These calcula-
tions yielded structures (Table S2) that were nearly
identical with NOE-only structures and exhibited no
NOE violationsN0.5Å.
CCPs 11 and 12 are more intimately associated
than CCPs 10 and 11
Bi-modules FH 10–11 and FH 11–12 are bent (or
tilted) by ~118° and ~90°, respectively, away from a
linearly extended form. The surface area effectively
buried between the N-terminal (CCP 10) and the
C-terminal (CCP 11) halves of FH 10–11 (using the
peptide bond between the middle two residues of
the linker as a boundary) is only ~360Å2, consistent
with detection of just eight NOEs between these
modules. An inferred salt bridge (Supplementary
Fig. S7) links the first residue of the linker (Lys624,
the last residue of CCP 10 β-strand H) to Asp675 of
the CCP 11 FG β-turn. Residues Thr602 and Val604
from the CCP 10 β-strand E (paired with CCP 10
β-strand H) participate in inter‐modular van der Waals
contacts with CCP 11 residues His651 and Asp675
(in BD loop and FG β-turn, respectively). All four
contribute, along with alkyl portions of linker residues
Lys624, Val627 and Gln628, to a hydrophobic pocket
wedged between the modules (Fig. 5a). Polar side
chains of linker residues Glu625, Gln626 and Ser629
are solvent exposed on the convex surface of the
inter-modular bend.
In FH 11–12, side chains of the DE loop and
β-strand E of CCP 11 (Pro661, Arg662, Phe663 and
Leu664) make extensive van der Waals interactions
with alkyl portions of linker residues (while polar
portions are displayed on the convex surface of the
bend) and with a segment of the BD loop of CCP 12
(Tyr710, Tyr711 and Gly712) (Fig. 5b). All these side
chains are substantially buried in a hydrophobic
Fig. 4. Solution (NOE-derived) structures of FH 10–11 and FH 11–12. (a) The 20 lowest-energy, water-minimized FH
10–11 structures, overlaid on backbone atoms of CCP 10 (blue), CCP 11 (magenta) or both modules CCP 10 and 11 (and
linker; wheat ) (relevant rmsd values are shown). (b) As (a) except that NOE-derived structures of FH 11–12 (CCP 12 in
gray) are overlaid. In the cartoon representations of (c) FH 10–11 and (d) FH 11–12, β‐strands identified by STRIDE were
labeled A–H according to a convention whereby CCP modules have a maximum of eight β‐strands. Spheres represent
cysteine side chains (sulfurs are colored yellow).
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pocket in FH 10–11—the surface area buried
between modules 11 and 12 is ~640Å2.
In summary, CCPs 11 and 12 are welded together
at an ~90° tilt in the structure calculation by a
substantial number of mutually compatible NOEs
reflecting extensive interactions and burial of a
sizeable surface area. Modules 10 and 11 are
mutually orientated at an even greater bend angle
to accommodate (NOE-supported) interactions be-
tween strand E of CCP 10 and the CD and FG loops
of CCP 11. Only a small surface area is buried
between CCPs 10 and 11, but a Lys624–Asp675 salt
bridge may stabilize it.
FH 10–12 can be modeled from SAXS data and
concatenation of bi-modules
Samples of FH 10–12 did not yield NMR spectra
suitable for structure determination. This problem,
encountered in previous efforts to solve triple-
CCP‐module structures,33,52 was ascribed to
anisotropic tumbling yielding lower T2 values
than a globular protein of comparable mass.Broad peaks and crowded spectra precluded
identification of sufficient inter-modular and mod-
ule-to-linker NOEs without more elaborate isotopic
labeling. Nonetheless, FH 10–12 yielded useful
SAXS data. Three methods were used to combine
results of SAXS for FH 10–12 and NMR for FH
10–11 and FH 11–12.
First, a model of FH 10–12 built by concatenating
FH 10–11 and FH 11–12 structures (Fig. 6a and b)
was validated on the basis of successful fitting to
SAXS data for FH 10–12 (χ=0.8) (Fig. 6c) using the
same method (see above) as employed for bi-
modules. Second, in an ab initio approach, also
similar to that described for the bi-modules, the
average solution structure of FH 10–12 was recon-
structed from SAXS data. As with the bi-modules,
independent reconstructions yielded similar shapes
(average normalized spatial discrepancies=0.73±
0.12), while discrepancies between models and
experimental data were low (χ=0.88±0.01), where-
as the total excluded dummy-atom volume of the
model matched the expected monomeric molecular
mass. Encouragingly, the average ab initio shape
superimposed well with, and thereby validated, the
Fig. 5. Inter‐modular interfaces in FH 10–11 and FH 11–12. (a) Side chains of residues involved in the interfaces drawn
as color-coded labeled spheres: blue for CCP 10, magenta for CCP 11 and gray for CCP 12; wheat for the CCP 10–11 or
the CCP 11–12 linker. (b) With the use of identical color coding, solvent-accessible surfaces are drawn, illustrating more
extensive contacts between CCPs 11 and 12 despite larger tilt angle between CCPs 10 and 11.
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mentary Fig. S2b). Finally, a combined FH 10–12
NOE list was compiled by concatenating FH 10–11
and FH 11–12 NOEs in a way that eliminated
duplication or conflict of NOEs originating from the
mutual CCP 11. Then, FH 10–12 structures were
calculated using simulated annealing, employing as
restraints both SAXS data and the combined NOE
list. As with bi-modules, ensembles (n=1 or 2) of
structures were derived, with energy terms calculat-
ed as ensemble averages. Calculated FH 10–12
structures were in good agreement with the
concatenated model, with each other and with both
NOE and SAXS data.
The ensemble optimization method (EOM)62 was
used to investigate flexibility of FH 10–12. In an initial
application, NMR-derived structures of individual
CCPs 10, 11 and 12 were used as rigid bodies and
linker regions defined as flexible chains of dummy
atoms to generate a pool of random conformations.Sets of conformers from the pool whose combined
theoretical scattering pattern best fit the experimen-
tal data were then selected and compared to the
whole pool of conformers. The size distribution of the
selected ensemble (Fig. 7a) was narrower than that
of the random pool and skewed toward compact
conformations. Thus, the results of the EOM
analysis are consistent with rigidity of modular
connections and FH 10–12 not being significantly
flexible or particularly extended. A subsequent EOM
iteration was based on the observation of signifi-
cantly fewer NOEs between CCPs 10 and 11 than
between CCPs 11 and 12. Thus, CCPs 11 and 12
along with their linker were defined as a rigid body,
while the 10–11 linker was treated as flexible. The
resulting narrow size distribution (Fig. 7b) of the
selected ensemble suggests that the CCP 10–11
linker is not significantly flexible in the FH 10–12
context, notwithstanding the relatively small surface
area buried between modules.
Fig. 6. Structure of FH 10–12. (a) Overview of construction of the FH 10–12 model from concatenation of the FH 10–11
and FH 11–12 NMR structures. (b) Cartoon representation of a model of FH 10–12 built by concatenating structures of FH
10–11 and FH 11–12. Models are rotated about the horizontal axis by 90° and 180° relative to the topmost representation,
respectively (for color coding, see Fig. 4). (c) Scattering curve of FH 10–12 fitted to the concatenated structure allows
validation of the model.
303Structures of Factor H Modules 10–11 and 11–12Structure of FH 10–13 and reinterpreting SAXS
data for FH 10–15 and FH 8–15
FH 10–11, FH 11–12 and FH 12–1335 are all
relatively rigid, and FH 10–12 lacks significant
flexibility. Thus, inter‐modular angles are likely to be
preserved between bi-module and tetra-module con-
texts. Hence, a concatenated model of FH 10–13—
based on the three bi-module structures—should be
reliable. MODELLER was used to construct such a
model (Fig. 8), which shows how the curvature of
FH 10–11 does not follow the arc described by
FH 11–13, resulting in an out-of-plane zigzag struc-
ture. This model allowed reinterpretation of previously
analyzedSAXSdata for FH10–15andFH8–15with a
less ambiguous outcome. Given that sequence
directionality can be reliably inferred on the basis of
the concatenated model of FH 10–13, rigid-body
refinement of FH 10–15 consistently yields conforma-
tions with a compact C-terminal structure (Fig. 8); in
these conformations, CCPs 14 and 15 interact
intimately with CCP 13, which could have functionalimplications for the regulation of complement by FH as
discussed below.
To assess the effect of adding CCPs 8 and 9 to FH
10–15, we conducted EOM analysis on FH 8–15.
Lacking information to the contrary, all linkers
excluding CCPs 10–11, 11–12 and 12–13 were
defined as flexible. It was found that significant
populations of both extended and compact inter-
modular linker conformations were required in order
to fit the data, resulting in a broad and bi-modal
population distribution (Fig. 7c). Assuming that the
FH 10–15 core remains rigid in the context of FH
8–15, this observation implies that CCPs 8 and 9 are
not tightly associated with the other six modules.
Interestingly, both SAXS data (Fig. 3) and a [1H,15N]
HSQC spectrum collected on recombinant FH 8–9
(data not shown) indicated that this bi-module is as
well folded as CCP 11–12 or 12–13. In conclusion,
structurally autonomous CCPs 8 and 9 (connected
to each other and to CCP 10 with well‐conserved
linkers) adopt a much less intimate association
with CCPs 10–13 than do CCPs 14 and 15; this
Fig. 7. Applications of the ensemble optimization method. (a) In FH 10–12, individual CCPs were defined as rigid bodies
but linkers were allowed to be flexible. Comparison of size distributions shows that an ensemble of structures selected from
the pool (continuous line) that fit optimally to the SAXS data for FH 10–12 is more compact than the pool of random
structures (broken line). (b) As in (a) except that, in this case, only the CCP 10–11 linker was permitted flexibility. Size
distributions are consistent with a rigid arrangement of CCPs 10 and 11 despite limited contacts between modules. (c) An
application of EOM to FH 8–15; all individual CCPs along with CCP pairs 10–11, 11–12 and 12–13 were defined as rigid
bodies while other linkers were treated as flexible. The selected ensemble indicates a mixture of compact and extended
conformers consistent with flexible attachment of CCPs 8 and 9 to a compact, relatively rigid core of CCPs 10–15.
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linker and structural dependency of CCP 14 on its
neighbors impose a uniquely compact arrangement
of CCPs 14 and 15 with CCPs 10–13.Discussion
Like all known CCP structures63 (except CCP
1335), CCPs 10, 11 and 12 approximate to flattened
prolate spheroids in which N and C termini occupy
opposite poles. Given relatively small cross-sec-
tional areas at intersections with neighbors, there
are limited ways in which a long string of CCPs
(such as FH) could attain the level of rigidity
presumably needed for functional cooperation be-
tween remote binding sites. The two N-terminal
modules of complement receptor type 2, for
example, exhibit side-by-side interactions because
the eight-residue inter-modular linker is long enough
to allow a 142° inter‐modular bend (away from
linearity).54 The rod-like architecture of FH CCP
19–20, on the other hand, arises from its minimal
three-residue linker that restricts tilt and ensures
interactions between loops on neighboring modules
so as to also limit twist.30,31
In the current work on FH 10–11, FH 11–12 and
FH 10–12, we describe two CCP–CCP junctions that
encompass six-residue inter-modular linkers. Byworking in solution, we minimized the risk for
observation of potentially anomalous inter-modular
tilts such as that observed between CCPs 18 and 19
in the crystal structure of FH 18–20.36 By combining
NMR and SAXS, we circumvented the need for
measurements of residual dipolar couplings wherein
interaction with alignment media carries a theoretical
risk of perturbing inter‐modular angles or dynamics.
The relatively long linkers among CCPs 10, 11 and
12 facilitate large tilts and consequently significant
inter-module interactions; their side chains also
contribute to the hydrophobic “glue” between adja-
cent modules. A broadly similar arrangement of
modules occurs in FH 12–13.35 Although previous
SAXS-based studies of FH 1–5, FH 6–8 and FH
16–20 also indicated bent-back structures,26 high-
resolution studies showed FH CCPs 1–3,33,34 FH
6–832 and CCPs 19–2036,47,64 to be linear or gently
curved. Thus, overlapping bi-modules FH 10–11, FH
11–12 and FH 12–13, connected by linkers of six or
eight residues and with tilts of about 80–100°,
represent the most strongly tilted succession of
four CCPs described to date. The FH conformation is
ionic strength dependent and pH sensitive65; it is
thus worth noting that equivalent His side chains
(His651 in FH 11 and His773 in FH 13) feature
prominently in both FH 10–11 and FH 12–13
interfaces while a salt bridge, Lys624–Asp675,
may stabilize the small FH 10–11 junction.
Fig. 8. A model of FH 10–13 helps interpret SAXS data for FH 10–15. (a) Cartoon representation of a concatenated
model of FH 10–13. (b) Two typical members of a convergent set of molecular structures that fit well to SAXS data for FH
10–15 interpreted on the assumption that CCPs 10–13 retain the spatial arrangement shown in (a), shown overlaid with the
reconstructed SAXS envelope from DAMMIF. (c) A cartoon representation of CCPs 10–15 derived from SAXS data. (d)
Zoom-in on CCPs 13–15 of SAXS-derived model; CCPs 14 and 15 bend over the CCP 12–13 linker in this model.
Asterisks indicate 13–14 and 14–15 linkers that were built into the fitted structure manually (using MODELLER) since they
were treated as dummy atoms during the fitting procedure.
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modular flexibility is consistent with the notion that
the middle portion of the FH molecule needs
flexional reinforcement if the ends (that carry the
binding sites) are to be held in (one or more)
preferred juxtaposition(s). An assumption that the
inter-modular angles observed in the bi-modules
10–11 and 11–12 would persist in the tri-module
FH 10–12 was validated by SAXS analysis. There-
fore, it was reasonable to concatenate the three bi-
modules to reconstruct CCPs 10–13, thus allowing
us to trace the path in space of four modules within
the central portion of FH. In agreement with a
previous analysis of SAXS data for FH 10–15,
CCPs 10–13 in this model do not all bend in the
same direction to form a horseshoe-like shape.
Instead, they form an out-of-plane S-shape or zigzag
because the CCP 10–11 bend does not follow the
curvature of CCPs 11–13.We could not extend this instructive NMR-sup-
ported exercise to CCPs 14 and 15, as it was
impossible to prepare the requisite samples of FH
13–14 or FH 14–15. No suitably stable samples
were produced despite repeated attempts to exploit
approaches that had previously proved successful
for numerous CCP module pairs and longer con-
structs. This may be a host-specific effect; for
example, low stability may arise from the lack of
appropriateN-glycosylation66 or the presence of a site
in folded CCP 14 that is uniquely susceptible to a
Pichia pastoris protease despite addition of protease
inhibitors. Nonetheless, several strands of evidence—
described below—suggest that this finding in fact
reflects a structural dependency of the common
module, that is, CCP 14, on one or more immediate
neighbors. Stabilizing interactions between CCP
modules were noted in several previous studies,67,68
and there are two reports of strand swapping between
306 Structures of Factor H Modules 10–11 and 11–12neighboring CCP modules69,70; moreover, a non-
compactly folded CCP module was discovered in the
GABAB receptor.
71 Thus, instability of CCP 14 in the
absence of neighboring modules would not be
unprecedented.
In previous SAXS-based studies of FH 10–15, one
of two molecular models that fitted the experimental
data featured CCP 14 folded back over CCP 13 with
extensive, potentially mutually stabilizing, interac-
tions between modules.35 The new solution struc-
tures of FH 10–11 and FH 11–12 allow a clearer
interpretation of the FH 10–15 SAXS data; impor-
tantly, they reinforce the case for a near-180° bend
between CCPs 13 and 14. Indeed, in the reinter-
preted SAXS and NMR-based model of FH 10–15,
CCP 14 contacts not only CCP 13 but also the 12–13
linker (Fig. 8). In the model, CCP 15 also contacts
both the 12–13 linker and CCP 13. Notably,
recombinant versions of single-module FH 13 and
FH 15, but not FH 14, were readily prepared, yielding
excellent NMR spectra. Moreover, relative well-
behaved samples of FH 11–14, FH 10–15,35 FH
15–18 and FH 15–1947 also proved relatively
straightforward to prepare. We were additionally
able to prepare unlabeled NMR samples of the tri-
module FH 13–15 although the quality of the 1HNMR
spectrum was inferior to that of other tri-modules.35
Taking all these observations together implies that,
for full stability, CCP 14 requires a stabilizing interface
with CCPs 12, 13 and 15. On the other hand, CCPs 13
and 15 do not require CCP 14 (or CCP 12) for stability;
rather, based on the lack of appropriate cross-peaks in
the HSQC spectrum of FH 13–14, the attachment of
putatively disordered CCP 14 to CCP 13, in the
module-pair context, actually destabilizes CCP 13. Its
highly conserved sequence is not suggestive of CCP
14 being unusual. Indeed, metaPrDOS72 does not
predict a disordered structure for the CCP 14
sequence. On the other hand, its interface with CCP
13 must indeed be irregular. First, the 13–14 linker is
themost variable (between orthologues) of any region
within the whole of FH; for example, the CCP 13–14
linker is TSKTS in mice and NEEAKIQL in cows. All
other 18 linkers are highly conserved. It is also the only
linker of human FH that forms part of an occupied N-
glycosylation sequence. Second, CCP 13 is poorly
conserved in sequence across orthologues. Third,
CCP 13 is less elongated than other CCPs and—
importantly—lacks the DE loop and β-strand H that
normally help to form a stable end-to-end interface
with a subsequent CCP. By contrast, CCPs 8 and 9
that are structurally independent, have (or are
predicted to have in the case of CCP 963) classical
CCP structures and are connected to each other and
CCP 10 by conserved linkers are flexibly associated
with the FH 10–13 unit.
Despite the low resolution of the NMR and SAXS-
derived model of CCPs 10–15, it is highly plausible.
According to the model, CCPs 12, 13, 14 and 15form a compact structural unit unlike any other
region of FH that has been described to date. CCPs
10, 11, 12 and 13 follow a more open zigzag path
with 90° tilts (see Fig. 8). CCPs 12 and 13 act as a
bridge between these two structural regions of FH
10–15 by participating in both of them. The linker
between CCPs 13 and 14 is very probably unique in
the FH molecule in that it has no structural role but
forms a flexible and exposed loop on its surface. The
positioning of CCP 13 in this model and the fact that
CCP 14 is tilted away, leaving the C-terminal end of
CCP 13 free, expose not only the non-conserved
13–14 linker but also an extensive highly variable
region of CCP 13 encompassing β-strand B and the
long BC loop (that includes a helical insertion), the
variable DE loop and the aforementioned (non-
conserved) N-glycosylation sequon adjacent to the
C-terminal cysteine. Note that the presence within
the central region of FH of large tilt angles or kinks is
consistent, both with best-fit models from SAXS
studies25 and with earlier transmission electron
micrographs of full-length FH.24
While the sequential series of inter‐modular tilts
between CCPs 10 and 13 contribute to flexional
reinforcement, the purpose of an extreme tilt at
13–14 is less clear. Further studies would be needed
to investigate whether this module pair could
correspond to the “hinge” in FH that has been
suggested35 as a means whereby the molecule can
switch rapidly between two conformations—a com-
pact or closed one (as reflected in FH 10–15) that
holds the two binding sites in such a way that they
have relatively low affinity for C3b73 and an “open”
one in which the two ends are able to bind
simultaneously, and with high affinity, to nonoverlap-
ping sites on a single molecule of C3b (or adjacent
C3b molecules) in the context of a self-surface and
its polyanionic markers. More investigation is re-
quired to test whether flexional stress or exposure to
the electronegative environment found at the host
surface disrupts the 13–14 interface. Under these
circumstances, module 14 would be likely to become
intrinsically disordered, creating a very flexible
segment within the FH molecule and allowing
terminal regions to cooperate in binding to a target.Materials and Methods
Protein production
Using procedures similar to those previously
described,30,74 we produced recombinant proteins in P.
pastoris. Very briefly, DNA encoding FH 10–11 (amino
acid residues 566–687), FH 11–12 (amino acid residues
627–747), FH 10–12 (amino acid residues 566–745), FH
13–14 (amino acid residues 748–865) or FH 14–15 (amino
acid residues 808–929) (numbers refer to unprocessed
initial human gene product) was PCR amplified from FH
307Structures of Factor H Modules 10–11 and 11–12cDNA. Each insert was ligated into a TOPO plasmid vector
subsequently used to transform Top10 Escherichia coli
cells (Invitrogen). The amplified plasmid was digested
(PstI and XbaI), and target DNA was ligated into the
pPICZα B vector (Invitrogen), 3′ of DNA coding for the
Saccharomyces cerevisiae α-mating factor secretion
signal that directs protein production into the secretory
pathway. Following amplification in E. coli cells and SacI
linearization, we used the plasmid to transform P. pastoris
KM71H. Transformed yeast cells were fermented, and
gene expression was induced with methanol. Following
centrifugal cell removal, we undertook purification from
media using ion-exchange chromatography, typically on
SP-Sepharose (GE Healthcare), normally followed by
size-exclusion chromatography on a Hi-Load 16/60 Super-
dex 75 120-mL column (GE Healthcare). Proteins bearing
high-mannose N-linked glycans were treated (after first
purification step) with Endo Hf (New England Biolabs).
Purification was monitored by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis under reducing and
nonreducing conditions; the molecular weight of the
purified material was validated with Fourier transform–ion
cyclotron mass spectrometry. For 15N enrichment, cells
were grown in minimal media supplemented with 15N-
labeled ammonium sulfate (Isotec, Sigma-Aldrich), glycer-
ol, basal salts, trace elements and vitamins and were
subsequently induced with methanol. For 13C,15N enrich-
ment, a similar protocol was used but cells were grown in
media containing 13C glucose (instead of glycerol), and
prior to induction with 13C methanol, 13C glycerol (Isotec,
Sigma-Aldrich) was added to facilitate derepression of the
alcohol oxidase promoter.Collection and processing of NMR data and
assignment of spectra
NMR spectra were collected at 298K on samples contain-
ing 10% (v/v) D2O in 5-mmNMR tubes, on Bruker AMX 800‐
and 600‐MHz instruments fitted with cryoprobes. Gradual
proteolysis occurred in the case of FH 10–11, necessitating
production of three 13C,15N-labeled NMR samples (at 400,
150 and 500μM in 20mM potassium phosphate buffer,
pH6.7). For FH 11–12, one 650‐μM 13C,15N-labeled sample
(in 20mM potassium phosphate buffer, pH6.3) sufficed. In
the case of FH 13–14, production of a properly folded and
stable sample suitable for NMR proved difficult (see
Results) and only a 15N-labeled sample (150μM in
20mM potassium phosphate buffer, pH6.6) was prepared.
Topspin version 1.3 (Bruker) was used to set up the
experiments, to acquire data and for initial data proces-
sing. The data were brought to their final format by
processing using AZARA (W. Boucher, Department of
Biochemistry, University of Cambridge, UK).
Resonance assignments were accomplished using the
CCPN Analysis software.75 For backbone assignments,
HBHANH (for FH 11–12), HBHA(CO)NH, CBCANH,
CBCA(CO)NH, HNCO and HN(CA)CO experiments were
collected. For side-chain assignments, HCCH–total corre-
lated spectroscopy (TOCSY), H(C)(CO)NH–TOCSY and
(H)C(CO)NH–TOCSY experiments were acquired along
with (two-dimensional) (HB)CB(CGCD)HD and (HB)
CB(CGCDCE)HE experiments for assigning aromatic
side chains.Solution structure determination
Including the nonnative N-terminal sequence (EAAG
and EAEAAG in FH 10–11 and FH 11–12, respectively),
88% of triple-resonance assignments, including 97% of
backbone atoms for FH 10–11 and 88%of triple-resonance
assignments, including 95% of backbone atoms for FH
11–12, were completed. Of the theoretically assignable
backbone atoms, the following weremissing: Pro632 (CO),
Pro633 (CO) and Asp675 (N and HN) in the case of FH
10–11 and Glu621 (H, HN, CO, Cα), Ala622 (H, HN and
Cα), Pro632 (CO, Cα), Pro633 (CO), Asp675 (N, HN),
Pro707 (CO) and Ile747 (CO) in the case of FH 11–12.
In one out of twelve in the case of FH 10–11 (Pro618)
and one out of ten in the case of FH 11–12 (Pro708), X-Pro
linkages were defined as cis, while the remainder were
defined as trans as judged by chemical shift differences
between Pro 13Cβ and 13Cγ atoms,76 by strong NOEs
observed between Hα (Xaa i−1) and Hα (Pro i) and between
Hα (Xaa i−1) and HN (Xaa i+1) and by no or weak detectable
NOEs between Hα (Xaa i−1) and Hδ (Pro i). Based on mass
spectrometry, all eight cysteine residues in both FH 10–11
and FH 11–12 were inferred to be in the oxidized state.
Specific disulfide bridges were incorporated into the final
rounds of structure calculations on the basis of NOEs
(reinforced by a precedent established by previous studies
of CCPs). Approximately 3% (for FH 10–11) and 14% (for
FH 11–12) of peaks in the 15N-edited NOE spectroscopy
spectra were assigned manually while, for both constructs,
~8% of peaks in the 13C-edited NOE spectroscopy spectra
were also assigned manually.
Remaining NOEs were assigned by a combination of
automated assignment and structure calculation. Thus,
seven cycles of CYANA 2.149 were employed for each of
FH 10–11 and FH 11–12 to generate lists of NOE-derived
distance restraints and sets of preliminary structures.
Once CYANA-generated parameters met published qual-
ity criteria,49 distance restraints were transferred into the
program CNS,50 using the CCPN Format Converter
program. Working within CNS allows structure refinement
against explicit water.Assessing and comparing structures
The quality of structures was assessed using
PROCHECK77 (see Table 1). A hydrogen–deuterium
exchange experiment was performed to cross-validate
hydrogen bonds observed in the NOE-derived structures;
for this purpose, lyophilized protein was transferred to
deuterated buffer, whereupon slowly exchanging amide
protons were identified in a [15N,1H]HSQC spectrum
collected 15min after exposure to D2O. Secondary
structure elements were identified using STRIDE.51
The Web server VADAR 1.878 was used to establish the
solvent accessible surface area (Å2); the buried surface
area was computed as (SA modulei+SA modulej)−SA bi-
moduleij, where CCP i was considered to encompass one
residue before its Cys(I) and three residues after its
Cys(IV), and CCP (j) boundaries were considered the third
residue before its Cys(I) and one residue after its Cys(IV).
Inter‐modular tilt, twist and skew angles29,79 were
determined using an in-house script†; a vector was chosen
between the principal axis of the inertia tensor (the z-axis)
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(CCP12), respectively, andwithmodule boundaries defined
as Cys(I), that is, Cys569 (CCP 10), Cys630 (CCP 11) or
Cys691 (CCP 12), and Cys(IV), that is, Cys623 (CCP 10),
Cys684 (CCP 11) or Cys744 (CCP 12), respectively.
Combinatorial extension80 was employed to compare
each experimentally determined CCP structure within the
complement system against the closest-to-mean individ-
ual structures determined herein.
SAXS data collection and interpretation
Synchrotron radiation X-ray scattering data were col-
lected on the X33 beamline of the European Molecular
Biology Laboratory (Deutsches Elektronen‐Synchrotron,
Hamburg) using a 1M PILATUS pixel detector (Dectris,
Switzerland) and eight frames of 15-s exposure time.
Samples were analyzed at 20°C, using protein concen-
trations of 0.3–10.7mg/mL in phosphate‐buffered saline.
The sample-to-detector distance was 2.7m, covering a
range of momentum transfer 0.08≤s≥6.0nm−1 [where s=
4πsin(θ)/λ , with 2θ being the scattering angle and λ=
0.15nm being the X-ray wavelength]. Based on compar-
ison of successive 15-s frames, samples in which radiation
damage was detected were further scrutinized and only
frames showing no significant change in intensity were
used for subsequent data analysis.
Data from the detectors were normalized to the
transmitted beam intensity and averaged, and the scatter-
ing of buffer solutions was subtracted. The difference
curves were scaled for solute concentration. Data manip-
ulations were performed using the ATSAS software
package81,82 utilizing the recently developed DATTOOL
library for averaging, merging and extrapolation to infinite
dilution from concentration series (Guinier regions for
samples at several concentrations, showing linearity;
Supplementary Fig. S8). The forward scattering I(0) and
radius of gyration Rg were determined from Guinier
analysis,83 assuming that, at very small angles (s≤1.3/
Rg), the intensity is represented as I(s)= I(0)exp((sRg)2/3).
These parameters were also estimated from the full
scattering curves using the indirect Fourier transform
method implemented in the program GNOM,84 along
with the distance distribution function p(r) and the
maximum particle dimensions Dmax. Molecular masses of
solutes were estimated from SAXS data by comparing the
extrapolated forward scattering with that of a reference
solution of bovine serum albumin (66kDa).
Fit of the NMR structures of FH fragments to the
SAXS data
The fits of the NMR-derived structures of FH fragments
to the SAXS data were conducted using the program
CRYSOL.57 CRYSOL calculates the partial scattering
amplitudes of proteins from their atomic coordinates,
taking into account the hydration layer and excluded
solvent volume. The number of harmonics was set to 50
and 256 points computed across the entire data range
(0bsb5nm−1). The NMR-derived structures were also
fitted to the SAXS data with Xplor-NIH using 500 solid
angles and 100 data points evenly distributed in a cubic
spline constructed using the SAXS data within the range
specified above.85Analysis of flexibility
Analysis of inter-module flexibility and size distribution of
possible conformers consistent with the measured scat-
tering data was conducted using the EOM.62 The EOM
selects an ensemble of possible conformations of input
rigid bodies (using the CCP modules 10, 11 and 12
determined in this study and the remaining modules as
described previously34) and user‐defined regions of
flexible sequence (here defined as the linkers between
CCP modules) from a pool of 10,000 randomly generated
models, using CRYSOL to calculate the theoretical
scattering profiles and a genetic algorithm, GAJOE, to
select the representative set that best describes the
experimental data.
Ab initio shape determination and molecular modeling
Low-resolution‐shape envelopes were determined using
the ab initio bead-modeling program DAMMIF.58 DAMMIF
represents the particle as a collection ofM densely packed
beads inside an adaptable and loosely constrained search
volume compatible with the experimentally determined Rg.
Each bead is randomly assigned to solvent (index=0) or
solute (index=1), and the particle structure in solution is
described by a binary string of length M. Disconnected
strings of beads are rejected, and the scattering ampli-
tudes are calculated. Simulated annealing is then used to
search for a compact model that minimizes the discrep-
ancy between the experimental and calculated intensities
of momentum transfer. The results of 10 independent
DAMMIF reconstructions were compared using
SUPCOMB1359 to determine the most representative
(typical) model. Averaged DAMMIF models were also
determined using DAMAVER, and these models were
adjusted such that they agree with the experimentally
determined excluded volume using DAMFILT.86
Molecular modeling used, as rigid bodies and where
appropriate, the same structures as used for EOM. Rigid-
body models were generated using the program CORAL,
an advanced version of the rigid-body modeling program
BUNCH81,87 where linkers/loops between individual sub-
units are represented as random polypeptide chains. The
results of 10 independent CORAL runs were analyzed
using the programs SUPCOMB13 and DAMAVER to
identify the most representative/typical models.Combining SAXS and NOEs
A concatenated FH 10–12 NOE list was created by
merging experimentally derived FH 10–11 and FH 11–12
NOE lists. Only NOEs from the FH 10–11 list that involve
residues in (and between) CCP 10, the CCP 10–11 linker
and the N-terminal half of the three‐dimensional structure
of CCP 11 were used; likewise, the only NOEs extracted
for use from the FH 11–12 list were those in (and between)
the C-terminal half of the three‐dimensional structure of
CCP 11, the CCP 11–12 linker and CCP 12. This
procedure, similar to that described previously,56 was
designed to remove potential duplications and conflict
involving the common CCP 11.
Structure calculations, incorporating the SAXS data for
FH 10–12 and the concatenated NOE list, were carried out
309Structures of Factor H Modules 10–11 and 11–12in Xplor-NIH version 2.30.55 A naive model of FH 10–
12, prepared using MODELLER 9v1088 by overlaying
closest-to-mean structures of FH 10–11 and FH 11–12
on the common CCP 11, was used as a starting
structure. In the first stage of a simulated annealing
protocol,55 the temperature was lowered from an initial
2000K to 600K in 50-K intervals, with 300 steps of
molecular dynamics at each temperature increment;
within this temperature interval, the energy terms were
progressively introduced by multiplicative ramping. In
the second stage, the structures were cooled from
600K to 100K, in increments of 25K, with 300 steps of
molecular dynamics at each temperature; potential
terms were statically set to the top values used in the
first stage of cooling. Two calculations were carried out:
first, a set of 100 standard protein structures was
calculated; second, 100 ensembles of structures (with
number of members N=2 in each ensemble) were
calculated. In the ensemble calculation, the energy
terms were calculated as an ensemble average, as
described before.61 Similar calculations were performed
for FH 10–11 and FH 11–12, using the relevant SAXS
data and NOE lists and NOE-only derived structures as
starting structures.
Relaxation data
Measurements of backbone 15N T1 and T2 and
1H,15N NOEs were conducted using a 600-MHz magnet
and 0.45‐nM and 0.65‐mM (for FH 10–11 and FH 11–
12, respectively) samples in 20mM potassium phos-
phate buffer, pH6.7 (FH 10–11) or pH6.3 (FH 11–12).
Delays used for T1 (ms) were (FH 10–11) 51.2, 51.2,
301.2, 501.2, 601.2, 751.2, 851.2 and 901.2 or (FH 11–
12) 51.2, 301.2, 501.2, 601.2, 701.2, 801.2 and 901.2.
Delays used for T2 (ms) (FH 10–11) were 16.96, 16.96,
33.92, 67.84, 101.76, 118.72, 135.68 and 152.64 or (FH
11–12) 16.96, 33.92, 67.84, 84.8, 101.76, 118.82 and
135.68. For heteronuclear NOE measurements, a
reference experiment with a 5-s relaxation delay was
followed by a second spectrum recorded with 1H
saturation achieved by a train of 120° pulses applied
for the last 3s of the 5-s delay to attain NOE build up.
The NMR data were processed using AZARA, and
spectra were assigned using Analysis.75 Relaxation
rates were obtained by fitting a single-exponential
decay to the extracted cross-peak height of each
residue using nonlinear fitting. In the case of FH 10–
11, the following native residues were excluded from the
analyses: Glu566, Arg567, Lys583, His613, Ser652 and
Gly676 (signals form the backbone amides were too
weak); Asp581, Val589, Val592, Phe595, Cys597,
Phe601, Val609, Val627, Thr645, Tyr649 and Ile671
(due to overlap); and Asp675 (amide not found). In the
case of FH 11–12, the following native residues were
excluded: Ser652, His735 and Gly736 (weak signals);
Tyr658, Leu697, Gln703, Tyr709, Ile731 and Cys733
(due to overlap); and Asp675 (amide not found).
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Glossary
Complement: Approximately 30 proteins involved in multiple
aspects of innate and acquired immunity.
Alternative pathway: Complement activation via spontaneous C3
hydrolysis; in contrast, antibody–antigen complexes and poly-
saccharides are needed to activate the classical and lectin
pathways, respectively.
C3: A complement protein that is cleaved by C3 convertase into
C3a and C3b; cleavage activates a thioester group in C3b that is
able to react with any nearby nucleophile.
C3(H2O): A form of C3 in which the thioester has been
spontaneously hydrolyzed; resembles C3b in domain arrange-
ments and ability to form part of a C3 convertase complex.
C3 convertase: Binary complex—C3(H2O).Bb or C3b.Bb—that
cleaves C3 to C3a and C3b; formation involves C3b or C3(H2O)
binding proenzyme factor B that subsequently gets cleaved (and
activated) by factor D to Bb.
CCP modules: Domains, which predominate among regulators of
complement activation, containing ~60 amino acid residues and
two disulfides.
